PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 106 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 3.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $527,612 | -39.6% | 200,613 | -18.9% | 0.00% | – |
| Q2 2023 | $873,096 | +8.4% | 247,336 | -5.1% | 0.00% | – |
| Q1 2023 | $805,177 | +10.8% | 260,575 | +51.6% | 0.00% | – |
| Q4 2022 | $726,955 | +22.8% | 171,857 | -31.4% | 0.00% | – |
| Q3 2022 | $592,000 | -30.6% | 250,365 | -16.4% | 0.00% | – |
| Q2 2022 | $853,000 | +141.0% | 299,477 | +143.6% | 0.00% | – |
| Q1 2022 | $354,000 | -10.4% | 122,930 | -5.5% | 0.00% | – |
| Q4 2021 | $395,000 | -79.7% | 130,098 | -53.1% | 0.00% | – |
| Q3 2021 | $1,946,000 | -23.1% | 277,508 | +0.7% | 0.00% | – |
| Q2 2021 | $2,529,000 | +11.9% | 275,538 | +18.5% | 0.00% | – |
| Q1 2021 | $2,260,000 | -26.6% | 232,508 | -22.6% | 0.00% | -100.0% |
| Q4 2020 | $3,081,000 | -35.8% | 300,264 | -36.9% | 0.00% | 0.0% |
| Q3 2020 | $4,801,000 | +182.7% | 475,771 | +192.2% | 0.00% | – |
| Q2 2020 | $1,698,000 | -42.1% | 162,805 | -53.1% | 0.00% | -100.0% |
| Q1 2020 | $2,933,000 | -51.4% | 347,468 | -49.6% | 0.00% | -50.0% |
| Q4 2019 | $6,037,000 | +1.3% | 689,976 | +24.6% | 0.00% | 0.0% |
| Q3 2019 | $5,961,000 | -60.2% | 553,700 | -53.0% | 0.00% | -71.4% |
| Q2 2019 | $14,974,000 | -33.5% | 1,178,143 | +103.1% | 0.01% | -41.7% |
| Q1 2019 | $22,503,000 | +144.1% | 580,117 | +28.1% | 0.01% | +140.0% |
| Q4 2018 | $9,217,000 | -83.5% | 452,917 | -62.8% | 0.01% | -80.0% |
| Q3 2018 | $55,750,000 | +3.4% | 1,215,931 | +33.4% | 0.02% | -7.4% |
| Q2 2018 | $53,922,000 | +946.0% | 911,608 | +1103.3% | 0.03% | +800.0% |
| Q1 2018 | $5,155,000 | -94.1% | 75,756 | -91.4% | 0.00% | -94.3% |
| Q4 2017 | $87,079,000 | -33.8% | 880,925 | -19.9% | 0.05% | -47.5% |
| Q3 2017 | $131,627,000 | +48.5% | 1,099,180 | +8.4% | 0.10% | +36.5% |
| Q2 2017 | $88,614,000 | +319.0% | 1,013,897 | +78.3% | 0.07% | +289.5% |
| Q1 2017 | $21,151,000 | +37.6% | 568,559 | +13.6% | 0.02% | +18.8% |
| Q4 2016 | $15,367,000 | +493.5% | 500,545 | +1196.7% | 0.02% | +700.0% |
| Q3 2016 | $2,589,000 | +142.4% | 38,600 | +6.2% | 0.00% | +100.0% |
| Q1 2016 | $1,068,000 | -95.2% | 36,349 | -87.2% | 0.00% | -95.8% |
| Q4 2015 | $22,299,000 | +155.4% | 284,427 | +145.5% | 0.02% | +200.0% |
| Q3 2015 | $8,730,000 | +4400.0% | 115,846 | +6887.1% | 0.01% | – |
| Q2 2015 | $194,000 | -88.4% | 1,658 | -76.6% | 0.00% | -100.0% |
| Q1 2015 | $1,673,000 | +192.0% | 7,087 | +133.9% | 0.00% | +100.0% |
| Q4 2014 | $573,000 | -99.3% | 3,030 | -99.1% | 0.00% | -98.8% |
| Q3 2014 | $77,055,000 | +317.9% | 322,989 | +15.6% | 0.08% | +285.7% |
| Q2 2014 | $18,440,000 | -82.7% | 279,401 | -72.7% | 0.02% | -83.2% |
| Q1 2014 | $106,464,000 | +58.4% | 1,022,316 | +57.5% | 0.12% | +43.7% |
| Q4 2013 | $67,219,000 | +582.0% | 649,277 | +253.5% | 0.09% | +480.0% |
| Q3 2013 | $9,856,000 | -0.9% | 183,674 | -18.1% | 0.02% | -11.8% |
| Q2 2013 | $9,946,000 | – | 224,144 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |